[Recommendations of the Committee of Andrology and Sexual Medicine of the AFU concerning the management of andrological and sexual medicine pathologies during the COVID-19 crisis].
Recommandations du Comité d’andrologie et de médecine sexuelle de l’AFU concernant la prise en charge andrologique et en médecine sexuelle en contexte et en sortie de crise sanitaire liée au COVID-19.
COVID-19
Collagenases
/ therapeutic use
Combined Modality Therapy
Erectile Dysfunction
/ drug therapy
Humans
Injections
Male
Pandemics
Penile Implantation
Penile Induration
/ diagnosis
Phosphodiesterase 5 Inhibitors
/ therapeutic use
Traction
Urologic Surgical Procedures, Male
Vacuum
Vasodilator Agents
/ therapeutic use
Verapamil
/ therapeutic use
COVID-19
Infertilité masculine
Maladie de Lapeyronie
Male infertility
Peyronie's disease
Priapism
Priapisme
Transsexualism
Transsexualisme
Vasectomie
Vasectomy
Journal
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
ISSN: 1166-7087
Titre abrégé: Prog Urol
Pays: France
ID NLM: 9307844
Informations de publication
Date de publication:
Historique:
received:
11
05
2020
revised:
20
07
2020
accepted:
13
08
2020
pubmed:
5
5
2021
medline:
16
6
2021
entrez:
4
5
2021
Statut:
ppublish
Résumé
To assist urologists in the management of andrological and sexual medicine pathologies during the COVID-19 crisis. Use of the formalized consensus method. The medical and surgical management of patients in andrology and sexual medicine must be adapted. Consultations should, as far as possible, be carried out by tele-consultation. For operative procedures, the delay between the operative decision and the date of (re)scheduling of the procedure will depend on: (1) the level of criticality of the clinical situation; (2) the type of intervention; (3) the functional and psychological repercussions, including quality of life while waiting for the procedure; (4) the notion of losing the chance of having an optimal outcome; (5) the risk of potential complications from delaying a procedure for too long; and (6) taking into account the patient's risk factors for severe forms of COVID-19. The protection of urologists from COVID-19 should be considered. Each urologist must make the best decision for the patient, taking into account the acceptable time frame and quality of life impact before surgical management, the COVID risk parameters, the technical and anesthetic feasibility and the structural possibility of the health care institution to ensure a specific dedicated pathway during the COVID-19 health crisis. The management of andrological and sexual medicine pathologies must be adapted to the COVID-19 crisis context. Some patients may require surgery, including in emergency. These recommendations are transitional and will end with the COVID-19 crisis.
Identifiants
pubmed: 33941462
pii: S1166-7087(20)30483-8
doi: 10.1016/j.purol.2020.08.001
pmc: PMC7434359
pii:
doi:
Substances chimiques
Phosphodiesterase 5 Inhibitors
0
Vasodilator Agents
0
Verapamil
CJ0O37KU29
Collagenases
EC 3.4.24.-
xiapex
EC 3.4.24.-
Types de publication
Journal Article
Practice Guideline
Langues
fre
Sous-ensembles de citation
IM
Pagination
495-502Investigateurs
C Burte
(C)
D Chevallier
(D)
B Delaunay
(B)
S Droupy
(S)
R El Osta
(R)
X Game
(X)
P Gayrel
(P)
F Giuliano
(F)
V Izard
(V)
R Mallet
(R)
A Ruffion
(A)
A Salin
(A)
L Savareux
(L)
F Staerman
(F)
Informations de copyright
Copyright © 2020 Elsevier Masson SAS. All rights reserved.